SCHEMBL30831018

SCHEMBL30831018

CCOC(=O)c1ccc([C@H]2C[C@@H](Nc3c(F)nn(C)c(=O)c3Br)CN(C)C2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 11/20 0.45
▸ BRD9 Q9H8M2 3/20 0.45
▸ BPTF Q12830 2/20 0.45
▸ BRD1 O95696 1/20 0.45
▸ ACHE P22303 1/20 0.45
▸ BRPF1 P55201 1/20 0.45
▸ KAT2A Q92830 1/20 0.45
▸ BRD7 Q9NPI1 1/20 0.45
▸ BAZ2B Q9UIF8 1/20 0.45
▸ BRPF3 Q9ULD4 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830531 0.87 KAT2B (0.52) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL31091698 0.82 KAT2B (0.68) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830841 0.78 KAT2B (0.56) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830860 0.77 KAT2B (0.55) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830970 0.76 KAT2B (0.68) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL31091738 0.73 KAT2B (0.54) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830795 0.73 KAT2B (0.73) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830560 0.73 KAT2B (0.73) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL31091762 0.72 KAT2B (0.54) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL31091717 0.71 KAT2B (0.73) KAT2BBPTFKAT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback